Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records.

From early May 2020 we dove right into finding a solution for COVID-19 crisis using our cutting edge quasi-quantum analysis and simulation platform. Our detailed findings are here.